Brainscape's Knowledge GenomeTM

Browse over 1 million classes created by top students, professors, publishers, and experts.


See full index

MEDICINAL ORGANIC CHEMISTRY > ANTINEOPLASTICS > Flashcards

ANTINEOPLASTICS Flashcards

You may prefer our related Brainscape-certified flashcards:
Periodic Table flashcards Chemistry 101 flashcards AP® Chemistry flashcards Organic Chemistry 101 flashcards
1
Q

1 gram of tumor is equivalent to

A

10^9 or 1 billion cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

A very common adverse reaction of alkylating agents used in the tx of cancer

A

Alopecia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

ALKYLATING AGENTS: NITROGEN MUSTARDS

Alkylating agents replace H with an alkyl group, which causes ____.

A

DNA strand breakage

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

ALKYLATING AGENTS: NITROGEN MUSTARDS

Mainstay therapy for solid tumors followed by autologous bone marrow transplantation

A

Thiotepa

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

ALKYLATING AGENTS: NITROGEN MUSTARDS

Dialkylating agent drug of choice for Hodgkin’s disease

A

Mechlorethamine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

ALKYLATING AGENTS: NITROGEN MUSTARDS

For germ cell testicular cancer

A

Ifosfamide

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

ALKYLATING AGENTS: NITROGEN MUSTARDS

Causes sulfur stripping

A

Busulfan

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

ALKYLATING AGENTS: NITROGEN MUSTARDS

Cell cycle non-specific phosphoramide mustard (major metabolite)

A

Cyclophosphamide

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

ALKYLATING AGENTS: NITROGEN MUSTARDS

For multiple myeloma

A

Melphalan

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

ALKYLATING AGENTS: NITROGEN MUSTARDS

1st line agent for chronic lymphocytic leukemia and macroglobulinemia

A

Chlorambucil

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

ALKYLATING AGENTS: ORGANOPLATINUM

MOA of organoplatinum

A

DNA strands cross-linking

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

ALKYLATING AGENTS: ORGANOPLATINUM

Most reactive and most effective in platinating DNA

A

Cisplatin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

ALKYLATING AGENTS: ORGANOPLATINUM

Carboplatin is administered with ____ to reduce toxicity

A

1,1-cyclobutane-dicarboxylate

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

ALKYLATING AGENTS: ORGANOPLATINUM

____ is administered with 1,1-cyclobutane-dicarboxylate to reduce toxicity

A

Carboplatin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

ALKYLATING AGENTS: ORGANOPLATINUM

Activated in low chloride environment, not recognized by MMR

A

Oxaliplatin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

ALKYLATING AGENTS

Alkylates DNA with restricted uncoiling and replication of strands

A

Nitrosoureas

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

ALKYLATING AGENTS: NITROSOUREAS

1st line agent for metastatic brain tumor

A

Lomustine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

ALKYLATING AGENTS: NITROSOUREAS

2nd line agent for Hodgkin’s disease

A

Lomustine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

ALKYLATING AGENTS: NITROSOUREAS

For brain tumors and can penetrate BBB

A

Carmustine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

ALKYLATING AGENTS: OTHERS

3 agents for Hodgkin’s lymphoma

A
  1. Mechlorethamine
  2. Lomustine
  3. Procarbazine
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

ALKYLATING AGENTS: OTHERS

2 agents that form DNA adducts

A
  1. Dacarbazine
  2. Temozolomide
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

ALKYLATING AGENTS: OTHERS

Involved in hydroxylation of methyl group

A

Altretamine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

ALKYLATING AGENTS: OTHERS

2nd line agent for ovarian cancer

A

Altretamine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

ALKYLATING AGENTS: OTHERS

Induces hyperglycemia on animal model

A

Streptozocin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

ALKYLATING AGENTS: OTHERS

Source of streptozocin

A

Streptomyces achromogenes subsp. Strepzoticus

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

ALKYLATING AGENTS: OTHERS

Antineoplastic that is not considered an anti-metabolite

A

Etoposide

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

Compounds closely related in structure to a cellular precursor (N-base)

A

Anti-metabolites

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

ANTI-METABOLITES

MOA of anti-metabolites

A

Prevention of biosynthesis by enzyme inhibition

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

ANTI-METABOLITES

Designed to interact at cofactor sites for enzymes involve in the biosynthesis of nucleic acid bases

A

Folates (Anti-folates)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
30
Q

ANTI-METABOLITES: FOLATES

First drug to produce substantial remissions in leukemia

A

Methrotrexate
(MTX)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
31
Q

ANTI-METABOLITES: FOLATES

MOA of Methrotrexate (MTX)

A
  1. Dihydrofolate reductase binding (DHFR)
  2. Thymidylate synthase (TS) interference
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
32
Q

ANTI-METABOLITES: FOLATES

A pyrrolopyrimidine analog

A

Pemetrexed

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
33
Q

ANTI-METABOLITES: FOLATES

MOA of Pemetrexed

A

Thymidylate synthase (TS) inhibition

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
34
Q

ANTI-METABOLITES: FOLATES

Structually similar to MTX and approved for the tx of pneumocystis carinii pneumonia (PCP) in HIV/AIDS patients

A

Trimetrexate

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
35
Q

ANTI-METABOLITES: FOLATES

MOA of hydroxyurea

A

Ribonucleotide Reductase inhibition

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
36
Q

ANTI-METABOLITES: PURINES

MOA of 6-mercaptopurine

A

De Novo Purine synthesis blocking

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
37
Q

ANTI-METABOLITES: PURINES

Primary treatment for acute leukemia

A

6-mercaptopurine + 6-thioguanine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
38
Q

ANTI-METABOLITES: PURINES

For chronic lymphocytic leukemia and non-Hodgkin’s lymphoma

A

Fludarabine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
39
Q

ANTI-METABOLITES: PURINES

Deoxyadenosine analog for hairy cell leukemia

A

Cladribine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
40
Q

ANTI-METABOLITES: PURINES

MOA of Pentostatin

A

Adenosine deaminase inhibition -> increase dATP

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
41
Q

ANTI-METABOLITES: PYRIMIDINES

Palliative tx of carcinoma of the breast, colon, pancreas, rectim, and stomach

A

5-Fluorouracil
(5-FU)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
42
Q

ANTI-METABOLITES: PYRIMIDINES

Fluoropyrimidine deoxynucleoside analog for GI adenocarcinoma metastatic to the liver

A

Floxuridine
(FUDR)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
43
Q

ANTI-METABOLITES: PYRIMIDINES

MOA of 5-FU and FUDR

A

Thymidylate synthase (TS) inhibition -> DNA synthesis inhibition

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
44
Q

ANTI-METABOLITES: PYRIMIDINES

Fluoropyrimidine carbamate prodrug of 5-FU for metastatic breast and colorectal cancer

A

Capecitabine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
45
Q

ANTI-METABOLITES: PYRIMIDINES

Drug of choice for locally advanced or metastatic adenocarcinoma of the pancreas

A

Gemcitabine

(+) Cisplatin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
46
Q

ANTI-METABOLITES: PYRIMIDINES

Drug of choice for inoperable locally advanced or metastatic NSCLC

A

Gemcitabine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
47
Q

ANTI-METABOLITES: PYRIMIDINES

A potent radiosensitizer

A

Gemcitabine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
48
Q

ANTI-METABOLITES: PYRIMIDINES

Cytosine arabinoside tx for acute agranulocytic leukemia

A

Cytarabine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
49
Q

ANTIBIOTICS

Antibiotic that do not possess clinically useful anti-malignant property

A

Streptomycin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
50
Q

ACTINOMYCIN

Source of dactinomycin

A

Strep. parvilus

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
51
Q

ACTINOMYCIN

Tx of rhabdomyosarcoma and Wilms’ tumor in children

A

Dactinomycin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
52
Q

ACTINOMYCIN

Lifesaving tx for women with choriocarcinoma resistant to MTX

A

Dactinomycin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
53
Q

ANTHRACYCLINES

MOA of anthracyclines

A
  1. Topoisomerase II inhibition
  2. Intercalation of the planar ring system
54
Q

ANTHRACYCLINES

Isolated from Strep. peucetius for non-lymphocytic and lymphocytic leukemia

A

Daunorubicin

55
Q

ANTHRACYCLINES

Cardiotoxic isolated from Strep. peucetius var. caesius

A

Doxorubicin

56
Q

ANTHRACYCLINES

No 4-methoxy group and terminal side chain for blast phase chronic myelogenous carcinoma

Less cardiotoxic than doxorubicin

A

Idarubicin

57
Q

ANTHRACYCLINES

4’-epimer of doxorubicin

A

Epirubicin

58
Q

ANTHRACYCLINES

BCG-refractory carcinoma of urinary bladder

A

Valrubicin

59
Q

ANTHRACYCLINES

Tint urine blue

A

Mitoxantrone

60
Q

GLYCOPEPTIDES

Isolated from Streptomyces verticillus

A

Bleomycin

61
Q

GLYCOPEPTIDES

Palliative treatment of squamous cell carcinoma with no myelotoxicity (bone marrow)

A

Bleomycin

62
Q

GLYCOPEPTIDES

Isolated from Streptomyces caespitosus

A

Mitomycin C

63
Q

GLYCOPEPTIDES

Bioreductive alkylating agents

A

Mitomycin C

64
Q

EPIPODOPHYLLOTOXIN (PLANT PRODUCTS)

Source of epipodophyllotoxins

A

Mayapple (Mandrake) Root

65
Q

EPIPODOPHYLLOTOXIN (PLANT PRODUCTS)

MOA of epipodophyllotoxins

A

Inhibition of microtubule function (topoisomerase II)

66
Q

EPIPODOPHYLLOTOXIN (PLANT PRODUCTS)

For testicular cancer and small cell lung cancer

A

Etoposide

67
Q

EPIPODOPHYLLOTOXIN (PLANT PRODUCTS)

A more potent inhibitor of topoisomerase II for acute lymphoblastic leukemia

A

Teniposide

68
Q

CAMPTOTHECINS (PLANT PRODUCTS)

MOA of camptothecins

A

Inhibitors of topoisomerase I

69
Q

CAMPTOTHECINS (PLANT PRODUCTS)

Source of camptothecins

A

Camptotheca acuminata

70
Q

CAMPTOTHECINS (PLANT PRODUCTS)

Semi-synthetic analog of camptotechin

A

Irinotecan

71
Q

CAMPTOTHECINS (PLANT PRODUCTS)

Drug of choice for metastatic colon cancer

A

5-FU + Leucovorin + Irinotecan

72
Q

CAMPTOTHECINS (PLANT PRODUCTS)

2nd line single agent in colorectal cancer

A

Irinotecan

73
Q

CAMPTOTHECINS (PLANT PRODUCTS)

A/E: Microscopic hematuria (blood in urine)

A

Topotecan

74
Q

VINCA ALKALOIDS (PLANT PRODUCTS)

Source of vinca alkaloids

A

Catharanthus roseus (periwinkle)

75
Q

VINCA ALKALOIDS (PLANT PRODUCTS)

MOA of vinca alkaloids

A

Arrest of mitosis
(Inhibition of microtubule polymerization)

76
Q

VINCA ALKALOIDS (PLANT PRODUCTS)

Dihydroindole nitrogen attached to vincristine

A

Formyl

77
Q

VINCA ALKALOIDS (PLANT PRODUCTS)

Dihydroindole nitrogen attached to vinblastine

A

Methyl

78
Q

VINCA ALKALOIDS (PLANT PRODUCTS)

ABVD regimen used in the treatment of
Hodgkin’s lymphoma

A
  1. Adriamycin
  2. Bleomycin
  3. Vinblastine
  4. Dacarbazine
79
Q

VINCA ALKALOIDS (PLANT PRODUCTS)

Extravasation with the use of vincas is managed by ____.

A

Hyaluronic Acid + Heat

80
Q

VINCA ALKALOIDS (PLANT PRODUCTS)

Semi-synthetic agent for NSCLC

A

Vinorelbine

81
Q

TAXANES (PLANT PRODUCTS)

Source of taxanes

A

Taxus brevifolia or Taxus baccatta (pacific yew tree)

82
Q

TAXANES (PLANT PRODUCTS)

Taxanes are administered with ____ and ____ due to poor water solubility

A
  1. Cremophor EL
  2. Ethanol
83
Q

TAXANES (PLANT PRODUCTS)

MOA of taxanes

A

β-tubulin binding

same with vincas

84
Q

TAXANES (PLANT PRODUCTS)

Highly plasma protein bound drug that promotes assembly of microtubules and may cause bradycardia

A

Paclitaxel

85
Q

TAXANES (PLANT PRODUCTS)

Semi-synthetic taxane that can cause reversible fluid retention

A

Docetaxel

86
Q

TAXANES (PLANT PRODUCTS)

Semisynthetic amide analog of epothilone B from Sorangium cellulosum

A

Ixabepilone

87
Q

PROTEIN (TYROSINE) KINASE INHIBITORS

Enzymes that add a phosphate (PO4) group to a protein or other organic molecule, which can turn a protein off

A

Protein kinases

88
Q

PROTEIN (TYROSINE) KINASE INHIBITORS

Inhibits epidermal growth factor receptor

A

Erlotinib

A/E: Acne, Diarrhea

89
Q

PROTEIN (TYROSINE) KINASE INHIBITORS

Inhibits BCR-ABL kinase and c-kit kinase

A

Imatinib

90
Q

PROTEIN (TYROSINE) KINASE INHIBITORS

Inhibits HER2/NEU activity

A

Lapatinib

91
Q

PROTEIN (TYROSINE) KINASE INHIBITORS

Inhibits intracellular and cell surface kinase like VEGFR

A

Sorafenib

92
Q

PROTEIN (TYROSINE) KINASE INHIBITORS

Inhibits receptor tyrosine kinases

A

Sunitinib

93
Q

HORMONES

Androgen receptor antagonist for advance prostate cancer

A

Bicalutamide and Flutamide

94
Q

HORMONES

Binds to estrogen receptor for the tx of metastatic breast cancer

A

Fulvestrant

95
Q

HORMONES

Inhibits gonadotropin secretion for prostate cancer

A

Leuprolide acetate

96
Q

HORMONES

A progesterone antagonist for advanced breast or endometrial cancer

A

Megestrol acetate

97
Q

HORMONES

Selective Estrogen Receptor Modulator (SERM) for advanced breast cancer in postmenopausal women

A

Tamoxifen

98
Q

HORMONES

Selective Estrogen Receptor Modulator (SERM) for advanced breast cancer in postmenopausal women

A

Tamoxifen

99
Q

HORMONES

A non-steroidal triphenylethylene agent for advanced breast cancer

A

Tamoxifen

100
Q

HORMONES

Benzothiophene derivative SERM

A

Raloxifene

101
Q

HORMONES

Palliative treatment for advanced prostate carcinoma, breast cancer, and endometriosis

A

Goserelin

102
Q

HORMONES

For inoperable adrenal cortical carcinoma

A

Mitotane

103
Q

HORMONES

Palliative treatment for metastatic breast cancer

A

Dromostanolone

104
Q

HORMONES

Palliative treatment for advanced or disseminated breast cancer

A

Testolactone

105
Q

HORMONES

For Cushing’s syndrome

A

Aminoglutethimide

106
Q

HORMONES

SERM for metastatic breast cancer

A

Toremifene

107
Q

HORMONES

Blocks conversion of androgen to estrogen

A

Aromatase Inhibitors

108
Q

AROMATASE INHIBITORS (HORMONES)

For hormone dependent breast cancer

A

Exemestane

109
Q

AROMATASE INHIBITORS (HORMONES)

First specific aromatase inhibitor for locally advanced or metastatic breast cancer

A

Anastrozole

110
Q

AROMATASE INHIBITORS (HORMONES)

Nonsteroidal aromatase inhibitors for locally advanced or metastatic breast cancer

A

Letrozole

111
Q

IMMUNOTHERAPY

For hairy cell leukemia and hairy cell leukemia in patients 18 years old or older

A

Interferon Alfa-2A

112
Q

IMMUNOTHERAPY

For hairy cell leukemia and malignant melanoma

A

Interferon Alfa-2B

113
Q

IMMUNOTHERAPY

Stimulates T-Cell growth and regulation, proliferation and immunoglobulin production in B lymphocytes, and macrophage activity enhancement

A

Aldesleukin

114
Q

MONOCLONAL ANTIBODIES

Binds to B and T cells

A

Alemtuzumab

115
Q

MONOCLONAL ANTIBODIES

Binds to vascular endothelial growth factor

A

Bevacizumab

116
Q

MONOCLONAL ANTIBODIES

Binds to CD33 on leukemic cells

A

Gemtuzumab

117
Q

MONOCLONAL ANTIBODIES

Binds to CD20 on lymphoid cells

A

Tositumomab

118
Q

MONOCLONAL ANTIBODIES

Genetically engineered chimeric monoclonal antibody against CD20 antigen expressed on the surfaces of malignant B lymphocytes

A

Rituximab

119
Q

MONOCLONAL ANTIBODIES

Single agent for metastatic breast cancer

A

Trastuzumab

120
Q

MONOCLONAL ANTIBODIES

Binds with human epidermal growth factor receptor type 2 (HER2) and neu receptor

A

Trastuzumab

121
Q

PROTEOSOME INHIBITOR

2 proteosome inhibitors

A
  1. Bortezomib
  2. Vorinostat
122
Q

MISCELLANEOUS

For acute promyelocytic leukemia (APL)

A

Arsenic Trioxide

123
Q

MISCELLANEOUS

For cutaneous T-cell lymphoma in patient refractory prior to systemic theraphy

A

Bexarotene

124
Q

MISCELLANEOUS

Adjunct therapy to prevent rejection of renal heterotransplants

A

Azathioprine

125
Q

MISCELLANEOUS

Enzyme from E. coli

A

Asparaginase

126
Q

MISCELLANEOUS

MOA of Asparaginase

A

Reduces asparagine in plasma makng it unavailable for leukemic cells

127
Q

MISCELLANEOUS

Promotes bone marrow recovery in patients who underwent autologous bone marrow transplantation

A

Sargramostim

128
Q

MISCELLANEOUS

GM-CSF from Saccharomyces cerevisiae or E. Coli

A

Sargramostim

129
Q

CYTOPROTECTIVES

For ifosfamide-induced hemorrhagic cystitis

A

Mesna

130
Q

CYTOPROTECTIVES

Reduce accumulative toxicity from cisplatin and xerostoma

A

Amifostine

131
Q

CYTOPROTECTIVES

Potent intracellular chelating agent to reduce doxurubicin toxicity

A

Dexrazoxane

MEDICINAL ORGANIC CHEMISTRY (17 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2024 Bold Learning Solutions. Terms and Conditions